850 related articles for article (PubMed ID: 15591481)
1. Efficacy of anticoagulation for secondary stroke prevention in older people with non-valvular atrial fibrillation: a prospective case series study.
Tsivgoulis G; Spengos K; Zakopoulos N; Manios E; Peppes V; Vemmos K
Age Ageing; 2005 Jan; 34(1):35-40. PubMed ID: 15591481
[TBL] [Abstract][Full Text] [Related]
2. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy.
Hohnloser SH; Pajitnev D; Pogue J; Healey JS; Pfeffer MA; Yusuf S; Connolly SJ;
J Am Coll Cardiol; 2007 Nov; 50(22):2156-61. PubMed ID: 18036454
[TBL] [Abstract][Full Text] [Related]
3. [Atrial fibrillation and thromboembolic events prevention. State of the art].
Matteoli S; Trappolini M; Chillotti FM
Minerva Cardioangiol; 2001 Feb; 49(1):1-13. PubMed ID: 11279381
[TBL] [Abstract][Full Text] [Related]
4. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
[TBL] [Abstract][Full Text] [Related]
5. Relation of effective anticoagulation in patients with atrial fibrillation to stroke severity and survival (from the National Acute Stroke Israeli Survey [NASIS]).
Schwammenthal Y; Bornstein N; Schwammenthal E; Schwartz R; Goldbourt U; Tsabari R; Koton S; Grossman E; Tanne D
Am J Cardiol; 2010 Feb; 105(3):411-6. PubMed ID: 20102959
[TBL] [Abstract][Full Text] [Related]
6. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
Agarwal S; Bennett D; Smith DJ
Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933
[TBL] [Abstract][Full Text] [Related]
7. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
[TBL] [Abstract][Full Text] [Related]
8. Bleeding during antithrombotic therapy in patients with atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators.
Arch Intern Med; 1996 Feb; 156(4):409-16. PubMed ID: 8607726
[TBL] [Abstract][Full Text] [Related]
9. Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation: a randomized multicenter study.
Pérez-Gómez F; Alegría E; Berjón J; Iriarte JA; Zumalde J; Salvador A; Mataix L;
J Am Coll Cardiol; 2004 Oct; 44(8):1557-66. PubMed ID: 15489085
[TBL] [Abstract][Full Text] [Related]
10. Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis.
Ruiz-Nodar JM; Marín F; Hurtado JA; Valencia J; Pinar E; Pineda J; Gimeno JR; Sogorb F; Valdés M; Lip GY
J Am Coll Cardiol; 2008 Feb; 51(8):818-25. PubMed ID: 18294566
[TBL] [Abstract][Full Text] [Related]
11. Stroke prevention in elderly patients with atrial fibrillation.
Lew SJ; Lim JK
Singapore Med J; 2002 Apr; 43(4):198-201. PubMed ID: 12188065
[TBL] [Abstract][Full Text] [Related]
12. Anticoagulant prophylaxis against stroke in atrial fibrillation: effectiveness in actual practice.
Caro JJ; Flegel KM; Orejuela ME; Kelley HE; Speckman JL; Migliaccio-Walle K
CMAJ; 1999 Sep; 161(5):493-7. PubMed ID: 10497604
[TBL] [Abstract][Full Text] [Related]
13. The effect and safety of the antithrombotic therapies in patients with atrial fibrillation and CHADS score 1.
Lee BH; Park JS; Park JH; Park JS; Kwak JJ; Hwang ES; Kim SK; Choi DH; Kim YH; Pak HN
J Cardiovasc Electrophysiol; 2010 May; 21(5):501-7. PubMed ID: 20021521
[TBL] [Abstract][Full Text] [Related]
14. Anticoagulation and atrial fibrillation.
Atwood JE; Albers GW
Herz; 1993 Feb; 18(1):27-38. PubMed ID: 8454250
[TBL] [Abstract][Full Text] [Related]
15. Gender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatment.
Poli D; Antonucci E; Grifoni E; Abbate R; Gensini GF; Prisco D
Thromb Haemost; 2009 May; 101(5):938-42. PubMed ID: 19404548
[TBL] [Abstract][Full Text] [Related]
16. Warfarin for the prevention of systemic embolism in patients with non-valvular atrial fibrillation: a meta-analysis.
Andersen LV; Vestergaard P; Deichgraeber P; Lindholt JS; Mortensen LS; Frost L
Heart; 2008 Dec; 94(12):1607-13. PubMed ID: 18208828
[TBL] [Abstract][Full Text] [Related]
17. Atrial fibrillation and stroke prevention with warfarin in the long-term care setting.
Gurwitz JH; Monette J; Rochon PA; Eckler MA; Avorn J
Arch Intern Med; 1997 May; 157(9):978-84. PubMed ID: 9140268
[TBL] [Abstract][Full Text] [Related]
18. Bleeding risk during oral anticoagulation in atrial fibrillation patients older than 80 years.
Poli D; Antonucci E; Grifoni E; Abbate R; Gensini GF; Prisco D
J Am Coll Cardiol; 2009 Sep; 54(11):999-1002. PubMed ID: 19729116
[TBL] [Abstract][Full Text] [Related]
19. Antithrombotic therapies for stroke prevention in atrial fibrillation.
Economides Muñoz C; Singh BN
Minerva Cardioangiol; 2004 Apr; 52(2):125-39. PubMed ID: 15194994
[TBL] [Abstract][Full Text] [Related]
20. Comparing the guidelines: anticoagulation therapy to optimize stroke prevention in patients with atrial fibrillation.
Rockson SG; Albers GW
J Am Coll Cardiol; 2004 Mar; 43(6):929-35. PubMed ID: 15028346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
